問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation

Division of Endocrinology

更新時間:2026-06-01

許嘉容
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2026-07-01 - 2028-12-31

Phase III

Not yet recruiting
A Randomized, Open-label, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Oral Semaglutide in Adults With Type 2 Diabetes Mellitus (Eluminate-2)
  • Condition/Disease

    Type 2 Diabetes Mellitus

  • Test Drug

    膜衣錠 錠劑

Participate Sites
10Sites

Not yet recruiting10Sites